Ugo De Giorgi Selected Research

Ugo De Giorgi Research Topics

Disease

93	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 10/2012
82	Neoplasms (Cancer) 10/2022 - 01/2002
66	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 08/2013
38	Neoplasm Metastasis (Metastasis) 07/2022 - 09/2005
22	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 01/2002
20	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
14	Disease Progression 01/2022 - 12/2018
14	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
11	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 05/2014
10	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 08/2016
7	Seminoma 10/2021 - 02/2005
7	Fatigue 01/2020 - 08/2013
6	Circulating Neoplastic Cells 01/2022 - 07/2009
6	Inflammation (Inflammations) 01/2021 - 01/2016
6	Human Influenza (Influenza) 01/2021 - 10/2018
5	Kidney Neoplasms (Kidney Cancer) 10/2022 - 01/2016
5	Pain (Aches) 01/2022 - 03/2015
5	Testicular Neoplasms (Testicular Cancer) 01/2022 - 02/2005
5	Neutropenia 12/2020 - 06/2003
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2012 - 03/2005
4	Diarrhea 01/2021 - 04/2014
4	Hypertension (High Blood Pressure) 01/2021 - 03/2014
3	Ovarian Epithelial Carcinoma 01/2021 - 12/2018
3	Pneumonia (Pneumonitis) 12/2020 - 07/2006
3	Autoimmune Diseases (Autoimmune Disease) 06/2020 - 01/2019
3	Urologic Neoplasms (Urological Cancer) 10/2019 - 01/2019
3	Stomatitis 01/2017 - 03/2015
3	Lymphopenia (Lymphocytopenia) 12/2015 - 08/2012

Drug/Important Bio-Agent (IBA)

31	enzalutamideIBA 04/2022 - 12/2014
26	abirateroneIBA 04/2022 - 06/2014
25	PlatinumIBA 02/2022 - 12/2016
24	Immune Checkpoint InhibitorsIBA 10/2022 - 04/2018
22	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
20	Sunitinib (Sutent)FDA Link 02/2022 - 08/2013
20	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 11/2015
17	Docetaxel (Taxotere)FDA Link 01/2022 - 06/2014
16	cabozantinibIBA 10/2022 - 01/2016
16	NivolumabIBA 10/2022 - 09/2016
15	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2015
15	pazopanib FDA Link 01/2022 - 08/2013
14	AndrogensIBA 03/2022 - 10/2012
14	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 01/2003
12	Bevacizumab (Avastin)FDA Link 02/2022 - 06/2011
12	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 06/2015
11	Biological ProductsIBA 01/2021 - 10/2016
9	Everolimus FDA Link 01/2022 - 10/2016
9	Hormones (Hormone)IBA 12/2021 - 03/2012
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2004
7	Pharmaceutical PreparationsIBA 07/2022 - 01/2015
7	Tyrosine Kinase InhibitorsIBA 02/2022 - 01/2015
6	atezolizumabIBA 02/2022 - 01/2018
6	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 06/2015
6	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 03/2014
6	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 03/2014
5	cabazitaxel FDA Link 01/2022 - 07/2015
5	AntigensIBA 01/2021 - 12/2017
5	CytokinesIBA 01/2019 - 01/2016
5	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 03/2005
4	LigandsIBA 02/2022 - 10/2016
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2015
4	infigratinibIBA 01/2022 - 01/2018
4	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2016
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 10/2018
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2015
4	Abiraterone AcetateIBA 12/2016 - 05/2015
4	human ERBB2 proteinIBA 03/2016 - 06/2011
3	IpilimumabIBA 10/2022 - 01/2022
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2019
3	Angiogenesis InhibitorsIBA 12/2021 - 05/2014
3	B7-H1 AntigenIBA 11/2021 - 01/2019
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2021 - 12/2016
3	Chimeric Antigen ReceptorsIBA 02/2021 - 10/2019
3	Gemcitabine FDA Link 01/2021 - 10/2004
3	gallium 68 PSMA-11IBA 11/2020 - 11/2018
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020 - 12/2016
3	Estrogen ReceptorsIBA 08/2020 - 08/2012
3	Taxoids (Taxanes)IBA 01/2020 - 01/2018
3	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2020 - 02/2016
3	taxaneIBA 01/2019 - 03/2015
3	Axitinib (AG 013736)IBA 01/2019 - 01/2016
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018 - 10/2004
3	Chromogranin AIBA 10/2018 - 06/2014
2	darolutamideIBA 03/2022 - 05/2021
2	Androgen Antagonists (Antiandrogens)IBA 03/2022 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 06/2011

Therapy/Procedure

84	Therapeutics 10/2022 - 06/2003
73	Castration 07/2022 - 10/2012
62	Drug Therapy (Chemotherapy) 02/2022 - 01/2002
15	Immunotherapy 01/2022 - 08/2016
9	Radiotherapy 01/2021 - 02/2005
6	Combination Drug Therapy (Combination Chemotherapy) 12/2021 - 01/2002
4	Salvage Therapy 01/2022 - 01/2002
4	Nephrectomy 01/2021 - 01/2016
4	Cystectomy 12/2020 - 04/2018
3	Aftercare (After-Treatment) 01/2021 - 01/2018
3	Adjuvant Chemotherapy 12/2020 - 03/2015
3	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2002
3	Drug Tapering 01/2017 - 04/2014
3	Transplantation 01/2017 - 04/2014